EUVIMEDEUVIMED entdecken
Crossref

Chondroprotective Effects of Chitosan‐Coated Poly(Lactic‐ co ‐Glycolic Acid) Nanocapsulized Curcumin on Human Articular Chondrocytes

Yung-Hsin Cheng, Chang-Chin Wu, Yueh-Hsin Chen, Pei-Feng Huang, Che-Wei Hsu, Koichi Kato, Kai-Chiang Yang iD

Journal of Biomedical Materials Research Part A · 2025

DOI: 10.1002/jbm.a.37969 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Biomedical Materials Research Part A, 2025. Verfasst von Yung-Hsin Cheng und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Materials Science and Engineering, National Taiwan University of Science and Technology, Taipei, Taiwan. Hauptthemen laut MEDLINE: Chitosan, Curcumin, Chondrocytes, Nanocapsules. Die Arbeit nennt 46 Literaturangaben. Gefördert von: Taipei Medical University and National Taiwan University of Science and Technology Joint Research Program.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Dysregulation of pro‐inflammatory cytokines participates in the initiation and development of knee osteoarthritis (OA). Consequently, interventions to boost the anti‐inflammatory capacity of articular chondrocytes have been proposed to treat early‐stage OA and prevent OA progression. Applying nanoencapsulation can enhance bioavailability and bioactivity and sustain the anti‐inflammatory activity of phytochemicals. Accordingly, in this study, we used nanocapsules to deliver curcumin (Cur) to treat inflammatory chondrocytes. Using double‐emulsion technology, Cur was encapsulated in chitosan‐coated poly(lactic‐co‐glycolic acid) nanocapsules. The nanocapsulized Cur (NCcur) was characterized, and the toxicity to human articular chondrocytes was evaluated. NCcur was applied to interleukin‐1 beta (IL‐1β)‐stimulated cells based on findings of the Cur toxicity study. Results showed that the particle size of NCcur was 247.8 ± 1.73 nm with a zeta potential of 20.3 ± 0.11 mV and a mid‐range distribution. NCcur showed a core‐shell and sphere‐like morphology. The encapsulation efficiency of Cur in nanocapsules was 67.1%. Nanoencapsulation decreased the toxicity of high‐dose Cur (> 20 μM), and NCcur exhibited a sustained Cur release over 72 h. NCcur supplementation (20 μM) improved cell survival and ameliorated cell senescence of inflammatory chondrocytes. The IL‐1β‐induced IL1B , IL6 , metalloproteinase‐9 ( MMP9 ), and MMP13 mRNA expressions were down‐regulated, while IL10 level was enhanced in NCcur‐treated chondrocytes. Likewise, NCcur supplementation restored aggrecan, collagen type II alpha 1 chain, and SOX9 mRNA expressions. MMP‐13, IL‐8, and MCP‐1 secretions in the supernatant also decreased. By applying nanocapsules, we assumed the anti‐inflammatory capacity of Cur could be sustained for treating knee OA.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ChitosanCurcuminChondrocytesNanocapsulesCartilage, ArticularPolyglycolic AcidLactic AcidCoated Materials, BiocompatibleHumansPolylactic Acid-Polyglycolic Acid CopolymerInterleukin-1betaCell SurvivalCells, Cultured

Stichwörter der Autor:innen

chondrocytescurcumininflammationnanocapsuleosteoarthritis

Substanzen

ChitosanCurcuminPolylactic Acid-Polyglycolic Acid CopolymerNanocapsulesPolyglycolic AcidInterleukin-1betaLactic AcidCoated Materials, Biocompatible

Autor:innen und Institutionen

  • Department of Materials Science and Engineering, National Taiwan University of Science and Technology, Taipei, Taiwan.
  • Department of Orthopedics, En Chu Kong Hospital, New Taipei City, Taiwan.
  • School of Dental Technology, College of Oral Medicine, Taipei Medical University, Taipei, Taiwan.
  • Department of Biomaterials, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan.
  • Orthopedics Research Center, Taipei Medical University Hospital, Taipei, Taiwan.

ORCID-Profile: Kai-Chiang Yang

Förderung

  • Taipei Medical University and National Taiwan University of Science and Technology Joint Research Program

Zitieren

APA

Cheng, Y. H., Wu, C. C., Chen, Y. H., Huang, P. F., Hsu, C. W., Kato, K., & Yang, K. C. (2025). Chondroprotective Effects of Chitosan‐Coated Poly(Lactic‐ co ‐Glycolic Acid) Nanocapsulized Curcumin on Human Articular Chondrocytes. Journal of Biomedical Materials Research Part A. https://doi.org/10.1002/jbm.a.37969

Vancouver

Cheng YH, Wu CC, Chen YH, Huang PF, Hsu CW, Kato K, et al. Chondroprotective Effects of Chitosan‐Coated Poly(Lactic‐ co ‐Glycolic Acid) Nanocapsulized Curcumin on Human Articular Chondrocytes. Journal of Biomedical Materials Research Part A. 2025. doi:10.1002/jbm.a.37969

BibTeX
@article{Cheng2025,
  author = {Cheng, Yung-Hsin and Wu, Chang-Chin and Chen, Yueh-Hsin and Huang, Pei-Feng and Hsu, Che-Wei and Kato, Koichi and Yang, Kai-Chiang},
  title = {Chondroprotective Effects of Chitosan‐Coated Poly(Lactic‐ co ‐Glycolic Acid) Nanocapsulized Curcumin on Human Articular Chondrocytes},
  journal = {Journal of Biomedical Materials Research Part A},
  year = {2025},
  doi = {10.1002/jbm.a.37969}
}
Kostenlos starten →